Wall Street Ends Mixed as Oil Slides on Iran Deal Hopes Micron Gains 56 GlobalFoundries Drops 9 Geopolitical Frictions Taiwan Arms Sales Emerge as Pivotal Point in TrumpXi Summit Gold Faces Potential Bearish Pressure as Peace Deal Hopes Diminish Reddit Shares Slide Nearly 6 After Meta Launches Standalone Forum App Pet Supplies Operator Files Chapter 11 Bankruptcy Amid Retail Sector Challenges Germanys Trade Minister Visits Beijing as EU Diverges on China Overcapacity Policy Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses Optex Systems Q1 2026 Earnings EPS of 003 as Stock Gains 173 TSAT Q1 2026 Earnings Massive EPS Miss Overshadows Missing Revenue as Stock Edges Higher NNDM Q1 2026 Earnings Loss Per Share of 034 as Stock Rises Amid Strategic Progress Adial Pharmaceuticals ADIL Q1 2026 Earnings NarrowerThanExpected Loss as Operational Progress Continues VRTS Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly Damora Therapeutics DMRA Gains 24 as Biotech Sector Finds Footing Solo Brands SBDS Slides 222 Testing Support Near 418 Amid Market Caution Globalstar Inc GSAT Edges Higher as Satellite Communications Sector Attracts Renewed Interest American Eagle Outfitters AEO Holds Near 1653 as Minimal Decline Tests Key Support Zone American States Water AWR Edges Higher Amid Steady Utility Demand Energy Utilities Roundup Market Talk Highlights Sector Dynamics SOFI Q1 2026 Earnings Narrow Earnings Miss Sends Stock Slightly Lower Worthington Enterprises WOR Shows Modest Gains Testing Key Resistance Levels NTB Q1 2026 Earnings EPS Surges Past Estimates by 82 YETI Q1 2026 Earnings Strong Profit Beat Drives Shares Higher ADAMH Q1 2026 Earnings Senior Notes Trust Surpasses Estimates with Strong Earnings Surprise Enbridge Inc ENB Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Performance MPC Q1 2026 Earnings Massive EPS Surprise of 1186 Highlights Operational Strength CRBP Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues INDP Q4 2025 Earnings EPS Misses Estimates as PreClinical Costs Continue Stock Declines 9